{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-039417","form_type":"8-K","ticker":"BNGO","cik":"0001411690","company_name":"Bionano Genomics, Inc.","filed_at":"2023-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.839238+00:00","generated_at":"2026-06-11T10:36:55.090223+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Bionano Genomics appoints Gülsen Kama as CFO effective September 11, 2023; Chris Stewart resigns","bullets":["Kama's base salary set at $460,000/year with 55% target bonus; receives option for 106,000 shares vesting over 4 years.","Kama also gets a one-time $150,000 signing bonus contingent on one year of continuous employment.","Stewart's severance includes lump sums equal to six weeks base salary, additional six weeks upon strategic milestone, and six months base salary cash.","Stewart will consult at $500/hour through November 11, 2023, with equity vesting continuing during consulting period.","Kama previously served as CFO of Northern Data AG and East Region & Healthcare IT CFO at Quest Diagnostics."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-039417","json":"https://secwatch.observer/filing/0001140361-23-039417.json","markdown":"https://secwatch.observer/filing/0001140361-23-039417.md","text":"https://secwatch.observer/filing/0001140361-23-039417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1411690/000114036123039417/0001140361-23-039417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1411690/000114036123039417/brhc20057474_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T10:36:55.090223+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25d7bdaf64","claim":"Gülsen Kama was appointed as Chief Financial Officer at Bionano Genomics, Inc..","evidence_excerpt":"On August 14, 2023, the Company announced the appointment of Gülsen Kama as Bionano Genomics, Inc.’s (the “Company”) Chief Financial Officer, effective as of September 11, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411690/000114036123039417/0001140361-23-039417-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"70779952c0","claim":"Christopher Stewart resigned as Chief Financial Officer at Bionano Genomics, Inc..","evidence_excerpt":"On August 11, 2023, Christopher Stewart resigned as Chief Financial Officer of the Company effective as of September 11, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1411690/000114036123039417/0001140361-23-039417-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}